Resmed (RSMDF) Total Liabilities (2010 - 2026)

Resmed (RSMDF) has reported Total Liabilities for 17 consecutive years, with $2.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 7.89% year-over-year to $2.4 billion; the trailing twelve-month figure through Jun 2026 stood at $2.4 billion (up 7.89% YoY), and the FY2026 full-year result was $2.4 billion, up 7.89% from the prior year.
• Total Liabilities advanced to $2.4 billion in Q2 2026 per RSMDF's latest filing, from $2.3 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $2.9 billion in Q4 2022 and bottomed at $1.6 billion in Q1 2022.
• Historically, Total Liabilities has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 84.91% in 2022, then fell 23.4% in 2024.
• Over 5 years, Total Liabilities stood at $2.9 billion in 2022, then retreated by 17.52% to $2.4 billion in 2023, then retreated by 22.07% to $1.9 billion in 2024, then advanced by 15.58% to $2.2 billion in 2025, then increased by 9.08% to $2.4 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $2.4 billion, $2.3 billion, and $2.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.